| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Walter Bodmer | Q7964332 |
| P2093 | author name string | Mortensen NJ | |
| Wheeler JM | |||
| P2860 | cites work | Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis | Q22122362 |
| Mutations of two PMS homologues in hereditary nonpolyposis colon cancer | Q24318484 | ||
| Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair | Q24318892 | ||
| Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability | Q24319995 | ||
| Mutations of mitotic checkpoint genes in human cancers | Q24320018 | ||
| Mutation and cancer: statistical study of retinoblastoma | Q24618185 | ||
| The Saccharomyces cerevisiae Msh2 and Msh6 proteins form a complex that specifically binds to duplex oligonucleotides containing mismatched DNA base pairs | Q27930815 | ||
| Enhancement of MSH2-MSH3-mediated mismatch recognition by the yeast MLH1-PMS1 complex | Q27932428 | ||
| Binding of insertion/deletion DNA mismatches by the heterodimer of yeast mismatch repair proteins MSH2 and MSH3. | Q27934985 | ||
| The Saccharomyces cerevisiae MLH3 gene functions in MSH3-dependent suppression of frameshift mutations | Q27935158 | ||
| Mutation of a mutL homolog in hereditary colon cancer | Q28114939 | ||
| Genetic instabilities in human cancers | Q28131826 | ||
| Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer | Q28253384 | ||
| The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer | Q28256988 | ||
| Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer | Q28257360 | ||
| Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients | Q72313890 | ||
| Unicryptal loss of heterozygosity in hereditary non-polyposis colorectal cancer | Q72634694 | ||
| Genomic instability occurs in colorectal carcinomas but not in adenomas | Q72649470 | ||
| Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history | Q72657539 | ||
| Pathology of hereditary non-polyposis colorectal cancer | Q72853899 | ||
| Association between CpG island methylation and microsatellite instability in colorectal cancer | Q73622839 | ||
| Microsatellite instability in human solid tumors | Q74546889 | ||
| MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers | Q74595724 | ||
| Excision repair invades the territory of mismatch repair | Q74610856 | ||
| Diagnosis of hereditary non-polyposis colorectal cancer | Q74802565 | ||
| Genetics of colonic cancer | Q77096087 | ||
| Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53 | Q77138798 | ||
| hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability | Q77804814 | ||
| Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region | Q28263090 | ||
| Genetic mapping of a locus predisposing to human colorectal cancer | Q28268634 | ||
| Biochemistry and genetics of eukaryotic mismatch repair | Q28282377 | ||
| A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Q28289377 | ||
| Isolation of an hMSH2-p160 Heterodimer That Restores DNA Mismatch Repair to Tumor Cells | Q28292781 | ||
| GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells | Q28292790 | ||
| Mutations of GTBP in genetically unstable cells | Q28292802 | ||
| Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases | Q28507226 | ||
| hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA | Q28610839 | ||
| Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha | Q28610863 | ||
| Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma | Q29615026 | ||
| Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair | Q29615027 | ||
| Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer | Q29615066 | ||
| Cancer epigenetics comes of age | Q29617275 | ||
| Genetic instability in colorectal cancers | Q29618711 | ||
| Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines | Q29620526 | ||
| Microsatellite instability in cancer of the proximal colon | Q29620692 | ||
| Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models | Q33758794 | ||
| 1998 Runme Shaw Memorial Lecture: somatic evolution of cancer | Q33781124 | ||
| Hereditary factors in cancer. Study of two large midwestern kindreds | Q34241416 | ||
| The mutation rate and cancer | Q34410886 | ||
| Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs | Q34554581 | ||
| The Escherichia coli MutL protein stimulates binding of Vsr and MutS to heteroduplex DNA. | Q34657088 | ||
| The molecular basis of Turcot's syndrome | Q34662365 | ||
| Cancer family “G” revisited: 1895-1970 | Q34701495 | ||
| Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. | Q34732921 | ||
| Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1. | Q35619996 | ||
| Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. | Q35764433 | ||
| Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma | Q35807817 | ||
| Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. | Q36213486 | ||
| Frameshift intermediates in homopolymer runs are removed efficiently by yeast mismatch repair proteins | Q36568343 | ||
| APC mutations in colorectal tumors with mismatch repair deficiency | Q37383704 | ||
| Sp1 binding is inhibited by (m)Cp(m)CpG methylation. | Q38343513 | ||
| Microsatellite instability in yeast: dependence on repeat unit size and DNA mismatch repair genes | Q40022200 | ||
| p53 and human cancers. | Q40648173 | ||
| BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. | Q40907031 | ||
| Apoptosis induced by overexpression of hMSH2 or hMLH1. | Q40943668 | ||
| Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review | Q41127594 | ||
| Mismatch repair defects in human carcinogenesis | Q41170340 | ||
| An update of HNPCC (Lynch syndrome). | Q41376773 | ||
| MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast | Q42427955 | ||
| Clues to the pathogenesis of familial colorectal cancer | Q42622043 | ||
| Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas | Q42677809 | ||
| Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours | Q42817159 | ||
| Morphology of sporadic colorectal cancer with DNA replication errors | Q43087650 | ||
| Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability | Q47704165 | ||
| Mismatch repair genes and mononucleotide tracts as mutation targets in colorectal tumors with different degrees of microsatellite instability | Q47801943 | ||
| Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred | Q48044118 | ||
| Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer | Q48084125 | ||
| Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. | Q50893078 | ||
| Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. | Q53445992 | ||
| Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. | Q53452567 | ||
| A century of progress in hereditary nonpolyposis colorectal cancer (Lynch syndrome). | Q53553203 | ||
| New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. | Q55033068 | ||
| 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers | Q55480673 | ||
| Cancer risk associated with germline DNA mismatch repair gene mutations | Q56813769 | ||
| Microsatellite Instability in Benign Skin Lesions in Hereditary Non-Polyposis Colorectal Cancer Syndrome | Q57337202 | ||
| Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog | Q57337207 | ||
| Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease | Q57567959 | ||
| Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients | Q57570041 | ||
| Interpretation of Genetic Test Results for Hereditary Nonpolyposis Colorectal Cancer | Q57591274 | ||
| A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines | Q57978042 | ||
| Genetic mapping of a second locus predisposing to hereditary non–polyposis colon cancer | Q58862199 | ||
| Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer | Q61946741 | ||
| The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) | Q62978412 | ||
| Microsatellite instability in the insulin–like growth factor II receptor gene in gastrointestinal tumours | Q63407701 | ||
| Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry | Q69648588 | ||
| Cancer family syndrome. Genetic analysis of 22 Finnish kindreds | Q69990101 | ||
| Extracolonic cancer in hereditary nonpolyposis colorectal cancer | Q70557907 | ||
| Colorectal adenomas in surgical specimens from subjects with hereditary non-polyposis colorectal cancer | Q70789109 | ||
| Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer | Q70870193 | ||
| Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas | Q70972741 | ||
| Familial colonic cancer without antecedent polyposis | Q71317779 | ||
| Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer | Q71520203 | ||
| Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers | Q71729088 | ||
| Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes | Q71733947 | ||
| Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability | Q72127255 | ||
| Immune surveillance in colorectal carcinoma | Q72293575 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| DNA mismatch repair | Q2984243 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 148-153 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | DNA mismatch repair genes and colorectal cancer | |
| P478 | volume | 47 |
| Q34777582 | 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. |
| Q35723844 | An Integrative Approach for Mapping Differentially Expressed Genes and Network Components Using Novel Parameters to Elucidate Key Regulatory Genes in Colorectal Cancer. |
| Q39325874 | An Unusual Variant of Adenocarcinoma of the Left Colon Associated With Microsatellite Instability: A Case Report |
| Q38328409 | Analysis of the interaction between the Saccharomyces cerevisiae MSH2-MSH6 and MLH1-PMS1 complexes with DNA using a reversible DNA end-blocking system. |
| Q84591037 | Assessment of microsatellite instability in colorectal cancer patients from Brazil |
| Q44177099 | Association between Mismatch-repair Genetic variation and the Risk of Multiple Primary Cancers: A Meta-Analysis |
| Q51449182 | Association between methylation in mismatch repair genes, V600E BRAF mutation and microsatellite instability in colorectal cancer patients. |
| Q34270970 | Biochemical basis for dominant mutations in the Saccharomyces cerevisiae MSH6 gene |
| Q35026049 | Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature |
| Q54551065 | Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers. |
| Q45741007 | Colorectal cancer in Iran: immunohistochemical profiles of four mismatch repair proteins |
| Q47149577 | Combination of primary tumor location and mismatch repair status guides adjuvant chemotherapy in stage II colon cancer |
| Q83131182 | Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers |
| Q92004818 | DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy |
| Q34568596 | DNA mismatch repair defects: role in colorectal carcinogenesis |
| Q24647002 | DNA mismatch repair: molecular mechanism, cancer, and ageing |
| Q41441021 | Development of a new analog of SGK1 inhibitor and its evaluation as a therapeutic molecule of colorectal cancer |
| Q38289639 | Dominant Saccharomyces cerevisiae msh6 mutations cause increased mispair binding and decreased dissociation from mispairs by Msh2-Msh6 in the presence of ATP. |
| Q24793645 | Effects of camptothecin on double-strand break repair by non-homologous end-joining in DNA mismatch repair-deficient human colorectal cancer cell lines |
| Q36436073 | Engineered disulfide-forming amino acid substitutions interfere with a conformational change in the mismatch recognition complex Msh2-Msh6 required for mismatch repair |
| Q40146719 | Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. |
| Q37061792 | Epigenetics and colorectal cancer pathogenesis |
| Q39736506 | Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers |
| Q93163404 | Establishment and characterization of 18 human colorectal cancer cell lines |
| Q36265836 | Evaluation of microsatellite instability in tumors of central nervous system: A pilot study |
| Q39108890 | Genetic aberrations in childhood acute lymphoblastic leukaemia: application of high-density single nucleotide polymorphism array. |
| Q36696628 | Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. |
| Q57737908 | Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer |
| Q38730390 | Helicobacter pylori infection modulates the expression of miRNAs associated with DNA mismatch repair pathway. |
| Q35571225 | Hereditary nonpolyposis colorectal cancer: preventive management |
| Q35562099 | Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects |
| Q47375648 | INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma |
| Q35594804 | INK4a-ARF alterations in liver cell adenoma |
| Q46967606 | INK4a-ARF alterations in liver cell adenoma |
| Q90113851 | Immunotherapy, Inflammation and Colorectal Cancer |
| Q43429867 | Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation |
| Q53676958 | Mechanisms and anticarcinogenic effects of diet-related apoptosis in the intestinal mucosa. |
| Q33947093 | Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome. |
| Q34378429 | Methylation and colorectal cancer |
| Q36776983 | Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series |
| Q36779731 | Mismatch repair deficiencies transforming stem cells into cancer stem cells and therapeutic implications |
| Q44644581 | Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. |
| Q35234577 | Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma |
| Q55224542 | Mismatch repair protein expression in patients with stage II and III sporadic colorectal cancer. |
| Q33758325 | Mismatch repair proteins are activators of toxic responses to chromium-DNA damage |
| Q35760529 | Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer |
| Q28508841 | Mitochondrial dysfunction and increased sensitivity to excitotoxicity in mice deficient in DNA mismatch repair |
| Q28081871 | Mouse models of colorectal cancer as preclinical models |
| Q28506656 | Msh-2 suppresses in vivo mutation in a gene dose and lesion dependent manner |
| Q26769850 | Pharmacologic resistance in colorectal cancer: a review |
| Q34583335 | Prevention and chemoprevention of colorectal neoplasms |
| Q92287784 | Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma |
| Q43006449 | Proximal and progressive: adenomas in HNPCC. |
| Q34657323 | Review of histopathological and molecular prognostic features in colorectal cancer |
| Q57784305 | Stochastic Processes and Component Plasticity Governing DNA Mismatch Repair |
| Q35969977 | Symptomatic presentation of early colorectal cancer |
| Q37172151 | The genomics of colorectal cancer: state of the art. |
| Q44511151 | The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome |
| Q57190619 | Trinucleotide Repeat Expansion Diseases, RNAi, and Cancer |
| Q37507301 | Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC). |
| Q33675252 | Utility of p16 immunohistochemistry for the identification of Lynch syndrome |
| Q34619340 | When is molecular genetic testing for colorectal cancer indicated? |
| Q33726141 | miR-1290 Is a Biomarker in DNA-Mismatch-Repair-Deficient Colon Cancer and Promotes Resistance to 5-Fluorouracil by Directly Targeting hMSH2. |
Search more.